Microsoft: A Critical Point in Valuation Momentum
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
Arbutus Biopharma (ABUS) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: May 24, 2025 (18:59)
Sector: HealthcareThe share price of Arbutus Biopharma Corp. (ABUS) now
Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2025, 2026, 2027. How much will one Arbutus Biopharma share be worth in 2025 - 2027?
When should I take profit in Arbutus Biopharma stock? When should I record a loss on Arbutus Biopharma stock? What are analysts' forecasts for Arbutus Biopharma stock? What is the future of Arbutus Biopharma stock? We forecast Arbutus Biopharma stock performance using neural networks based on historical data on Arbutus Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Arbutus Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arbutus Biopharma shares. This happens once a day.
Historical and forecast chart of Arbutus Biopharma stock
The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Arbutus Biopharma stock price can be found in the table below.
Long-term forecasts by years.
Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.
Arbutus Biopharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 3.28 | 3.26 | 3.29 | 1.10 |
| May 27 | 3.28 | 3.25 | 3.30 | 1.33 |
| May 28 | 3.27 | 3.25 | 3.28 | 0.70 |
| May 29 | 3.28 | 3.27 | 3.30 | 0.89 |
| May 30 | 3.29 | 3.27 | 3.31 | 1.22 |
| May 31 | 3.31 | 3.29 | 3.32 | 0.70 |
| Jun 01 | 3.31 | 3.30 | 3.31 | 0.45 |
| Jun 02 | 3.30 | 3.30 | 3.33 | 0.97 |
| Jun 03 | 3.33 | 3.31 | 3.34 | 1.14 |
| Jun 04 | 3.34 | 3.33 | 3.34 | 0.47 |
| Jun 05 | 3.35 | 3.32 | 3.37 | 1.41 |
| Jun 06 | 3.37 | 3.34 | 3.39 | 1.49 |
| Jun 07 | 3.37 | 3.35 | 3.40 | 1.39 |
| Jun 08 | 3.37 | 3.35 | 3.38 | 1.16 |
| Jun 09 | 3.39 | 3.36 | 3.40 | 1.14 |
| Jun 10 | 3.42 | 3.40 | 3.44 | 1.17 |
| Jun 11 | 3.43 | 3.41 | 3.45 | 1.05 |
| Jun 12 | 3.45 | 3.42 | 3.48 | 1.52 |
| Jun 13 | 3.43 | 3.42 | 3.46 | 1.19 |
| Jun 14 | 3.44 | 3.43 | 3.45 | 0.74 |
| Jun 15 | 3.43 | 3.41 | 3.45 | 1.12 |
| Jun 16 | 3.40 | 3.39 | 3.41 | 0.62 |
| Jun 17 | 3.41 | 3.39 | 3.42 | 0.87 |
| Jun 18 | 3.41 | 3.39 | 3.43 | 1.17 |
| Jun 19 | 3.44 | 3.43 | 3.46 | 0.81 |
| Jun 20 | 3.43 | 3.41 | 3.44 | 1.03 |
| Jun 21 | 3.44 | 3.43 | 3.46 | 0.76 |
| Jun 22 | 3.46 | 3.45 | 3.48 | 1.07 |
| Jun 23 | 3.45 | 3.44 | 3.47 | 0.66 |
| Jun 24 | 3.44 | 3.42 | 3.47 | 1.42 |
Arbutus Biopharma Daily Price Targets
Arbutus Biopharma Stock Forecast 05-26-2025.
Forecast target price for 05-26-2025: $3.28.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.086%.
Pessimistic target level: 3.26
Optimistic target level: 3.29
Arbutus Biopharma Stock Forecast 05-27-2025.
Forecast target price for 05-27-2025: $3.28.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.313%.
Pessimistic target level: 3.25
Optimistic target level: 3.30
Arbutus Biopharma Stock Forecast 05-28-2025.
Forecast target price for 05-28-2025: $3.27.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 0.698%.
Pessimistic target level: 3.25
Optimistic target level: 3.28
Arbutus Biopharma Stock Forecast 05-29-2025.
Forecast target price for 05-29-2025: $3.28.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 0.885%.
Pessimistic target level: 3.27
Optimistic target level: 3.30
Arbutus Biopharma Stock Forecast 05-30-2025.
Forecast target price for 05-30-2025: $3.29.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.204%.
Pessimistic target level: 3.27
Optimistic target level: 3.31
Arbutus Biopharma Stock Forecast 05-31-2025.
Forecast target price for 05-31-2025: $3.31.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 0.699%.
Pessimistic target level: 3.29
Optimistic target level: 3.32
ABUS (ABUS) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 3.38 | 3.15 | 3.53 | 10.75 |
| Jul. | 3.39 | 3.27 | 3.69 | 11.42 |
| Aug. | 3.23 | 3.05 | 3.32 | 8.23 |
| Sep. | 3.32 | 3.17 | 3.52 | 9.97 |
| Oct. | 3.38 | 3.26 | 3.47 | 5.89 |
| Nov. | 3.59 | 3.32 | 3.81 | 12.93 |
| Dec. | 3.44 | 3.36 | 3.67 | 8.55 |
Arbutus Biopharma forecast for this year
Arbutus Biopharma Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $3.38293. Pessimistic: $3.15. Optimistic: $3.53
Arbutus Biopharma Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $3.3941. Pessimistic: $3.27. Optimistic: $3.69
Arbutus Biopharma Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $3.22982. Pessimistic: $3.05. Optimistic: $3.32
Arbutus Biopharma Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $3.31864. Pessimistic: $3.17. Optimistic: $3.52
Arbutus Biopharma Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $3.37705. Pessimistic: $3.26. Optimistic: $3.47
Arbutus Biopharma Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $3.58508. Pessimistic: $3.32. Optimistic: $3.81
Arbutus Biopharma Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $3.43916. Pessimistic: $3.36. Optimistic: $3.67
Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.56 | 3.48 | 3.65 | 4.62 |
| Feb | 3.75 | 3.67 | 3.90 | 6.03 |
| Mar | 3.87 | 3.77 | 4.00 | 5.76 |
| Apr | 3.70 | 3.61 | 4.01 | 10.13 |
| May | 3.40 | 3.12 | 3.70 | 15.87 |
| Jun | 3.66 | 3.46 | 3.91 | 11.51 |
| Jul | 3.98 | 3.74 | 4.16 | 10.10 |
| Aug | 3.89 | 3.74 | 4.03 | 7.23 |
| Sep | 4.26 | 4.13 | 4.47 | 7.66 |
| Oct | 4.12 | 4.01 | 4.40 | 8.85 |
| Nov | 4.40 | 4.13 | 4.52 | 8.77 |
| Dec | 4.41 | 4.11 | 4.78 | 14.11 |
Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.09 | 3.77 | 4.19 | 9.88 |
| Feb | 4.11 | 3.94 | 4.41 | 10.68 |
| Mar | 3.89 | 3.61 | 3.99 | 9.43 |
| Apr | 3.76 | 3.43 | 4.02 | 14.71 |
| May | 3.74 | 3.53 | 4.03 | 12.37 |
| Jun | 4.01 | 3.89 | 4.11 | 5.37 |
| Jul | 3.96 | 3.74 | 4.15 | 9.96 |
| Aug | 4.00 | 3.74 | 4.13 | 9.28 |
| Sep | 3.73 | 3.41 | 3.85 | 11.30 |
| Oct | 3.58 | 3.43 | 3.86 | 11.20 |
| Nov | 3.67 | 3.55 | 3.82 | 7.19 |
| Dec | 3.29 | 3.03 | 3.47 | 12.60 |
Arbutus Biopharma information and performance
100-8900 GLENLYON PARKWAY, BURNABY, BC, CA
Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.
EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Arbutus Biopharma Stock)
Should I Buy Arbutus Biopharma Shares in 2025 year?
Does Arbutus Biopharma pay dividends?
Which economic sector do Arbutus Biopharma's shares belong to?
Which other securities belong to the same sector as Arbutus Biopharma's shares?
